I would think that the introduced RARE tRNAs should be kept at a level similar to those of the endogenous tRNAs. The companies that supply these strains should have the information.
I think the overall level of tRNAs are the same. However, Rosetta is optimized to provide a more reflective ratio of eukaryotic preferred yRNAs for at least R, I, L, and V.